The PAN Foundation announces its 2024 Board of Directors
Today, the PAN Foundation—one of the nation’s leading patient advocacy and charitable patient assistance foundations—announced its 2024 Board of Directors, which provides governance, oversight, and strategic direction to the organization. In addition to welcoming three new board members, the PAN Foundation also announced its 2024 slate of board officers, which include:
- Board Chair: James Dunlop, JD, MD – Dermatologist and Dermatologic Surgeon, InterMed
- Board Vice Chair: Nancy McGee, JD, MPH, DrPH – Senior Vice President, Lumanity
- Board Secretary: Mary Findley, MS, CPA, CHC – Senior Director, Alvarez & Marsal Healthcare Industry Group
The following new directors join the PAN Foundation Board of Directors in 2024:
- Jon Sellman – Managing Director, Global Brand Management & Content, Citi
- Sarah Thomason, PharmD – Interim Chair and Professor of Pharmacy Practice, East Tennessee State University Gatton College of Pharmacy
- Elizabeth Wade, PharmD – Patient Safety Officer, Amazon Pharmacy
PAN Board members continuing to serve in 2024 include:
- Chase Bice – Partner, PwC US Business Advisory LLP
- Mary Blunt – Senior Corporate Vice President of Healthcare Operations, Sentara Healthcare (retired)
- Jennifer Brown – Chief Administrative Officer and General Counsel, Graphite Health
- Wendy Bullington, PharmD – Internal Medicine Pharmacist, Medical University of South Carolina
- Joseph M. D’Avella, CPA – Owner, Joseph M. D’Avella, CPA
- Nicholas Larochelle, MD – Medical Director, Concord Hospital System Emergency Medicine and Patient Access Value Stream
- Anna McKean – Chief Executive Officer, Master Center for Addiction Medicine
- Winfred Parnell, MD – Associate Clinical Professor of Obstetrics and Gynecology, University of Texas Southwestern Medical Center (retired)
- Howard M. Weinberg, DO, FACC – Cardiologist, Virtual Health Cardiology, and Associate Clinical Professor of Medicine, Rowan School of Osteopathic Medicine
“It is a privilege to serve alongside this group of respected and dedicated individuals who share a commitment to improving the lives of the patients we serve,” said Board Chair Dr. James Dunlop. “I’m eager to see what we are able to accomplish together this year as we continue to make strides to improve healthcare access, affordability, and equity for all.”
In addition, Deanna Banks of Furst Group and Jeffrey King, JD, of Sentara Healthcare (retired) completed six years of service on the Board effective December 31, 2023.
“On behalf of the entire PAN Foundation organization, I would like to offer my sincere thanks to Deanna and Jeffrey for their six years of service and leadership, including Deanna’s exemplary service as Board Chair,” said PAN Foundation President and CEO Kevin L. Hagan. “During their tenure, the PAN Foundation supported hundreds of thousands of patients and achieved major advocacy wins. Their contributions will continue to guide us as we serve hundreds of thousands more and expand our advocacy impact.”
About the PAN Foundation
The PAN Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic, and rare diseases with the out-of-pocket costs for their prescribed medications.
Since 2004, we have provided more than 1.1 million underinsured patients with more than $4 billion in financial assistance. Partnering with generous donors, healthcare providers, and pharmacies, we provide the underinsured population access to the healthcare treatments they need to best manage their conditions and focus on improving their quality of life. Learn more at panfoundation.org.